MicroRNA dysregulation in pemphigus: a systematic review of expression profiles and molecular targets
7 affiliations
- 1Faculty of Medicine, University of Cyberjaya
- 2School of Pharmacy, KPJ Healthcare University
- 3Faculty of Pharmacy, University of Cyberjaya
- 4ASASIpintar Unit, Pusat PERMATA@Pintar Negara, Universiti Kebangsaan Malaysia
- 5Faculty of Health Sciences, Universiti Kebangsaan Malaysia
- 6Faculty of Medicine, University of Sfax
- 7Research Laboratory LR18/SP12 “Autoimmunity, Cancer and Immunogenetics”, Habib Bourguiba Hospital, University of Sfax
Abstract
Pemphigus is a severe autoimmune bullous disease characterized by the production of pathogenic autoantibodies leading to acantholysis. Emerging evidence suggests that microRNA regulate immune responses and may contribute to disease pathogenesis. However, an updated, integrative synthesis linking miRNA expression profiles to their molecular targets remains lacking. This review specifically addresses the expression profiles, target genes, and molecular pathways of miR-338-3p, miR-146a-5p, miR-155-5p and miR-424-5p, and their potential involvement in pemphigus. Original studies investigating microRNA expression or functional roles in patients with pemphigus or relevant experimental models were considered eligible. A literature search was conducted in Scopus, PubMed and ScienceDirect scientific databases between January 2000 and September 2025. Titles, abstracts, and full texts were screened, by two independent researchers according to predefined eligibility criteria. A total of nine studies were included in this review. Clinical evidence establishes miR-338-3p, miR-155-5p, and miR-424-5p as robust diagnostic biomarkers of active disease, with AUC values reaching 0.988. Notably, miR-338-3p and miR-155-5p levels show significant positive correlations with PDAI scores. Mechanistically, for miR-338-3p, the genes RNF114, TRADD, and RUNX1 have been experimentally validated as direct targets, linking this miRNA to Th1/Th2 imbalance and the suppression of FOXP3-mediated Treg activity. Similarly, miR-146a-5p has been validated to target the NF-κB adaptors TRAF6 and IRAK1, acting as an endogenous anti-inflammatory regulator. These findings identify specific miRNA axes as potential therapeutic targets and high-precision tools for clinical stratification and disease severity. However, further large-scale and mechanistic studies are needed to validate their functional target genes and clinical utility.
Related
- Synaptic microRNA dysregulation orchestrates aberrant glutamatergic transmission in a human neuronal model of 22q11.2 deletion syndrome
- A deep generative decoder predicts microRNA expression from bulk and single-cell mRNA profiles
- Gene and microRNA Expression Profiling in Experimental Colitis and Human Ulcerative Colitis: Effects of STAT6 Knockout and Corylus avellana Treatment
- Social isolation is associated with microRNA expression changes in the visual system of poison frog tadpoles
- A human CHRNA6 3' UTR variant alters the molecular environment and microRNA engagement of the adolescent VTA without changing Chrna6 transcript abundance
BibTeX
@article{tahri2026microrna,
title = {{MicroRNA dysregulation in pemphigus: a systematic review of expression profiles and molecular targets}},
author = {Safa Tahri and Ching Siang Tan and Liew Kai Bin and Ee-Ling Siew and Hatem Masmoudi and Olfa Abida and Johnathan Malagobadan and Nor Kamalia Binti Zahari},
journal = {Frontiers in Immunology},
year = {2026},
month = oct,
doi = {10.3389/fimmu.2026.1871963},
url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1871963/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - MicroRNA dysregulation in pemphigus: a systematic review of expression profiles and molecular targets
AU - Safa Tahri
AU - Ching Siang Tan
AU - Liew Kai Bin
AU - Ee-Ling Siew
AU - Hatem Masmoudi
AU - Olfa Abida
AU - Johnathan Malagobadan
AU - Nor Kamalia Binti Zahari
PY - 2026
DA - 2026/10/23
JO - Frontiers in Immunology
DO - 10.3389/fimmu.2026.1871963
UR - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1871963/full
AB - Pemphigus is a severe autoimmune bullous disease characterized by the production of pathogenic autoantibodies leading to acantholysis. Emerging evidence suggests that microRNA regulate immune responses and may contribute to disease pathogenesis. However, an updated, integrative synthesis linking miRNA expression profiles to their molecular targets remains lacking. This review specifically addresses the expression profiles, target genes, and molecular pathways of miR-338-3p, miR-146a-5p, miR-155-5p and miR-424-5p, and their potential involvement in pemphigus. Original studies investigating microRNA expression or functional roles in patients with pemphigus or relevant experimental models were considered eligible. A literature search was conducted in Scopus, PubMed and ScienceDirect scientific databases between January 2000 and September 2025. Titles, abstracts, and full texts were screened, by two independent researchers according to predefined eligibility criteria. A total of nine studies were included in this review. Clinical evidence establishes miR-338-3p, miR-155-5p, and miR-424-5p as robust diagnostic biomarkers of active disease, with AUC values reaching 0.988. Notably, miR-338-3p and miR-155-5p levels show significant positive correlations with PDAI scores. Mechanistically, for miR-338-3p, the genes RNF114, TRADD, and RUNX1 have been experimentally validated as direct targets, linking this miRNA to Th1/Th2 imbalance and the suppression of FOXP3-mediated Treg activity. Similarly, miR-146a-5p has been validated to target the NF-κB adaptors TRAF6 and IRAK1, acting as an endogenous anti-inflammatory regulator. These findings identify specific miRNA axes as potential therapeutic targets and high-precision tools for clinical stratification and disease severity. However, further large-scale and mechanistic studies are needed to validate their functional target genes and clinical utility.
SN - 1664-3224
ER -